These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

554 related items for PubMed ID: 12427740

  • 1. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation.
    Fuks F, Hurd PJ, Wolf D, Nan X, Bird AP, Kouzarides T.
    J Biol Chem; 2003 Feb 07; 278(6):4035-40. PubMed ID: 12427740
    [Abstract] [Full Text] [Related]

  • 2. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC, Schübeler D, Groudine M.
    Mol Cell Biol; 2001 Dec 07; 21(23):7913-22. PubMed ID: 11689684
    [Abstract] [Full Text] [Related]

  • 3. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex.
    Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A.
    Nature; 1998 May 28; 393(6683):386-9. PubMed ID: 9620804
    [Abstract] [Full Text] [Related]

  • 4. Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation.
    El-Osta A, Kantharidis P, Zalcberg JR, Wolffe AP.
    Mol Cell Biol; 2002 Mar 28; 22(6):1844-57. PubMed ID: 11865062
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Epigenetic regulation of metallothionein-i gene expression: differential regulation of methylated and unmethylated promoters by DNA methyltransferases and methyl CpG binding proteins.
    Majumder S, Kutay H, Datta J, Summers D, Jacob ST, Ghoshal K.
    J Cell Biochem; 2006 Apr 15; 97(6):1300-16. PubMed ID: 16329111
    [Abstract] [Full Text] [Related]

  • 7. Methylation-dependent silencing at the H19 imprinting control region by MeCP2.
    Drewell RA, Goddard CJ, Thomas JO, Surani MA.
    Nucleic Acids Res; 2002 Mar 01; 30(5):1139-44. PubMed ID: 11861904
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibitors of histone deacetylase and DNA methyltransferase synergistically activate the methylated metallothionein I promoter by activating the transcription factor MTF-1 and forming an open chromatin structure.
    Ghoshal K, Datta J, Majumder S, Bai S, Dong X, Parthun M, Jacob ST.
    Mol Cell Biol; 2002 Dec 01; 22(23):8302-19. PubMed ID: 12417732
    [Abstract] [Full Text] [Related]

  • 10. Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.
    Nguyen CT, Gonzales FA, Jones PA.
    Nucleic Acids Res; 2001 Nov 15; 29(22):4598-606. PubMed ID: 11713309
    [Abstract] [Full Text] [Related]

  • 11. MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin.
    Nan X, Campoy FJ, Bird A.
    Cell; 1997 Feb 21; 88(4):471-81. PubMed ID: 9038338
    [Abstract] [Full Text] [Related]

  • 12. Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1.
    Kimura H, Shiota K.
    J Biol Chem; 2003 Feb 14; 278(7):4806-12. PubMed ID: 12473678
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneity in the modification and involvement of chromatin components of the CpG island of the silenced human CDH1 gene in cancer cells.
    Koizume S, Tachibana K, Sekiya T, Hirohashi S, Shiraishi M.
    Nucleic Acids Res; 2002 Nov 01; 30(21):4770-80. PubMed ID: 12409468
    [Abstract] [Full Text] [Related]

  • 14. Biochemical analysis of histone deacetylase-independent transcriptional repression by MeCP2.
    Theisen JW, Gucwa JS, Yusufzai T, Khuong MT, Kadonaga JT.
    J Biol Chem; 2013 Mar 08; 288(10):7096-104. PubMed ID: 23349465
    [Abstract] [Full Text] [Related]

  • 15. Release of methyl CpG binding proteins and histone deacetylase 1 from the Estrogen receptor alpha (ER) promoter upon reactivation in ER-negative human breast cancer cells.
    Sharma D, Blum J, Yang X, Beaulieu N, Macleod AR, Davidson NE.
    Mol Endocrinol; 2005 Jul 08; 19(7):1740-51. PubMed ID: 15746193
    [Abstract] [Full Text] [Related]

  • 16. Methyl-CpG-binding protein MeCP2 represses Sp1-activated transcription of the human leukosialin gene when the promoter is methylated.
    Kudo S.
    Mol Cell Biol; 1998 Sep 08; 18(9):5492-9. PubMed ID: 9710633
    [Abstract] [Full Text] [Related]

  • 17. A mutant form of MeCP2 protein associated with human Rett syndrome cannot be displaced from methylated DNA by notch in Xenopus embryos.
    Stancheva I, Collins AL, Van den Veyver IB, Zoghbi H, Meehan RR.
    Mol Cell; 2003 Aug 08; 12(2):425-35. PubMed ID: 14536082
    [Abstract] [Full Text] [Related]

  • 18. The DNA methyltransferases associate with HP1 and the SUV39H1 histone methyltransferase.
    Fuks F, Hurd PJ, Deplus R, Kouzarides T.
    Nucleic Acids Res; 2003 May 01; 31(9):2305-12. PubMed ID: 12711675
    [Abstract] [Full Text] [Related]

  • 19. Gene silencing by methyl-CpG-binding proteins.
    Nan X, Cross S, Bird A.
    Novartis Found Symp; 1998 May 01; 214():6-16; discussion 16-21, 46-50. PubMed ID: 9601009
    [Abstract] [Full Text] [Related]

  • 20. DNA methyltransferase Dnmt1 associates with histone deacetylase activity.
    Fuks F, Burgers WA, Brehm A, Hughes-Davies L, Kouzarides T.
    Nat Genet; 2000 Jan 01; 24(1):88-91. PubMed ID: 10615135
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.